Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2025-12-26 @ 1:35 AM
NCT ID: NCT01918033
Description: The population consisted of all participants who received at least one dose of study drug.
Frequency Threshold: 5
Time Frame: Up to 2 weeks after last dose of study drug (up to 4 weeks)
Study: NCT01918033
Study Brief: A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Desloratadine 5 mg Participants receive one desloratadine 5 mg tablet and one placebo tablet orally once daily for up to 2 weeks None None 1 202 11 202 View
Desloratadine 10 mg Participants receive two desloratadine 5 mg tablets orally once daily for up to 2 weeks None None 0 203 17 203 View
Placebo Participants receive two placebo tablets orally once daily for up to 2 weeks None None 0 201 9 201 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Epilepsy SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA 16.1 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Nasphopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA 16.1 View